The Federal Governments announcement today that MTPConnect, in partnership with BioCurate, UniQuest and the Medical Device Partnering Program, will operate the $22.3 million Biomedical Translation Bridge program has been welcomed by the organisations CEO, Dr Dan Grant.
A novel program to drive commercialisation skills in the burgeoning digital health sector has received new funding from the Medical Technologies and Pharmaceuticals Growth Centre, MTPConnect.
MTPConnect and our partners, the Western Australian State Government and the University of Western Australia, are pleased to announce the appointment of Associate Professor Kevin Pfleger as our Director Stakeholder Engagement for Western Australia.
In a boost for Australia’s medical technologies and pharmaceuticals sector, the Federal Government has provided an additional two years of funding for the sector’s Growth Centre, MTPConnect.
A new report on opportunities for Australia's burgeoning regenerative medicine sector reveals it has all the elements needed to be a global leader and drive the creation of thousands of new, high paying jobs.
Three key life sciences projects have been awarded a total of $690,000 in new funding to support researchers, improve collaboration with industry and open-up international market opportunities.
MTPConnect has expanded its alliance with the influential The Medical Alley Association of Minnesota to open-up linkages for Australian researchers and firms in the United States.
MTPConnect in conjunction with the Western Australian Government and The University of Western Australia (UWA), is delighted to announce the establishment of the Western Australian Node (the WA Node) of MTPConnect in Perth, to support the state's burgeoning life sciences sector.
MTPConnect - the Australian Government's Medical Technology, Biotechnology, and Pharmaceutical (MTP) Industry Growth Centre - is excited to support the launch of a new Australian initiative - Clinical Trials: Impact & Quality (CT:IQ), an inclusive collaboration to ensure the effective and efficient promotion of clinical trials in Australia.
MTPConnect - the Australian Government's Medical Technology, Biotechnology, and Pharmaceutical (MTP) Industry Growth Centre - is delighted to announce that it has appointed Dr Dan Grant as Chief Executive Officer.
MTPConnect – the Australian Government’s Medical Technology, Biotechnology, and Pharmaceutical (MTP) Industry Growth Centre – and the Minister for Health, the Hon Greg Hunt MP, today announced the first 11 recipients of $10 million investment from the Australian Government’s $35 million BioMedTech Horizons program.
MTPConnect - the Australian Government's Medical Technology, Biotechnology, and Pharmaceutical (MTP) Industry Growth Centre - and BioPacific Partners - an organisation helping global companies connect to Australian innovations - are jointly launching an exciting new initiative to assist Australian medical technology and pharmaceutical companies to better prepare and position themselves to engage successfully with multinational companies.
MTPConnect - the Medical Technology, Biotechnology and Pharmaceutical Industry Growth Centre - has today announced changes to the Board and Executive team for 2018.
MTPConnect has released new sector metrics that show jobs supported by the MTP sector increased by 10% to 62,000 from 2015 to 2016, and that manufacturing exports are up by 30% to $5.2 billion.